spudgene

PSILOCYBIN

Spud Gene’s team of scientists has achieved a remarkable breakthrough in Iran by successfully extracting and purifying the active compound psilocybin from the Psilocybe cubensis mushroom with a purity level exceeding 99.9% and in accordance with global standards. After extensive testing and expert analysis in the research and development department, the exclusive industrial production formula of this valuable product, recognized as a revolutionary advancement in the pharmaceutical industry worldwide, has entered the production phase in Spud Gene’s advanced facilities. Spud Gene proudly introduces itself as the first and only producer of psilocybin in the country. The company offers psilocybin in three forms: solution, solid crystals, and powder, accompanied by a Certificate of Analysis (COA).

History of Psilocybin (Magic Mushroom)

Psilocybin magic mushrooms have a rich history dating back thousands of years. Archaeological evidence shows that indigenous cultures in various regions such as South America, Central America and Africa have been using psychedelic mushrooms in religious and healing ceremonies for centuries. Their use is often intertwined with cultural practices and spiritual beliefs. The cultural significance of psilocybin magic mushrooms lies in their ability to induce altered states of consciousness and facilitate profound experiences. Psilocybin users often experience a sense of interconnectedness, spiritual insight, increased empathy, and a sense of transcendence. These experiences are often sought for personal growth, self-reflection, creativity and exploration of the human mind. As the level of awareness and research on magic mushrooms and their uses increases, there is a growing interest in exploring their therapeutic potential.

Magic mushroom is used as a new and innovative treatment method to improve people's psychological and psychological well-being. This technique relies on the use of psilocybin, a natural chemical found in mushroom fungi. This substance acts as a chemical messenger in the brain and has positive effects on a person's mood, creativity, awareness and life experience.

The effects of magic mushroom on psychology:

Magic mushroom can have positive effects on a person's psychology. Studies have shown that taking psilocybin can improve a person's mood, reduce anxiety, and increase creativity and concentration. Also, this technique can improve anxiety and depression associated with mental illnesses such as major depression, anxiety disorders and post-traumatic stress disorder.

Mechanism of action of Magic Mushroom:

Psilocybin works in the brain and by affecting the central nervous system, it causes changes in nerve activity and neural networks. These changes may increase neural connections, increase the secretion of psychological agents, etc. Please leave the article description so I can continue.

Discussion and conclusion about the active substance of psilocybin

Psilocybin is a substance that has received much attention in recent years due to its therapeutic properties in the treatment of psychological disorders. In many studies, the therapeutic effects of this compound in the treatment of addictive disorders (alcohol, tobacco, etc.), post-traumatic stress disorder (PTSD), generalized anxiety disorder (GAD), obsessive-compulsive disorder (OCD), cancer-related anxiety In the advanced stage, adjustment disorder with anxiety, cancer-related depression, treatment-resistant depression, suicidality (actual thought and attempt), cluster headaches, chronic pain, intractable phantom pain, maladaptive narcissism, borderline personality disorder (BPD), Narcissistic personality disorder (NPD), bulimia nervosa, epilepsy and Alzheimer's have been investigated and confirmed. Psilocybin treatment offers new hope for people suffering from mental health disorders.

Definition of Depression

Depression is a common mood disorder that affects approximately 5% of adults worldwide. This disorder leads to a continuous feeling of sadness, loss of interest in daily activities, and a decrease in motivation. It can occur due to problems in school, work, or personal life, and can lead to further difficulties in various areas. Contrary to popular belief, depression is different from normal mood and emotional changes related to everyday life and can severely impact all aspects of life, including relationships with family, friends, and society, to the extent that it may even result in suicide in severe cases. Individuals can conceal the symptoms of depression to the point where they appear happy, healthy, and normal, making it challenging to diagnose and provide appropriate treatment. Depression can affect anyone, although individuals who have experienced abuse, loss of loved ones, or other stress-inducing events are more susceptible to developing depression. It is estimated that around 7% of the global population experiences a major depressive disorder annually. However, these numbers are not very precise as many individuals suffering from depression do not seek medical help. The prevalence of depression is three times higher in individuals aged 18 to 29 compared to those over 60 years old. Additionally, women are 1.5 to 3 times more likely to experience depression than men during adolescence.

Symptoms of Depression and Diagnostic Criteria

The diagnostic stage is one of the most important steps as it determines the approach and Depression Treatment plan. The examination of depression symptoms begins by assessing changes in sleep pattes, appetite, and energy levels. At least five of the following criteria are necessary for a clinical diagnosis (one of the symptoms must be either a depressed mood or loss of interest or pleasure):

1. Sleep disturbances
2. Loss of interest or pleasure
3. Feelings of guilt or worthlessness
4. Fatigue and disrupted energy levels
5. Impaired concentration and attention
6. Changes in appetite and weight
7. Depressed mood
8. Disturbances in sexual desire

Among these, all patients with depression should be evaluated for suicidal risk. Any suicide risk should be promptly addressed, which may involve hospitalization or close and frequent monitoring. After assessing the aforementioned criteria, the physician also studies the patient’s medical, family, and social background to make an appropriate evaluation for selecting the treatment plan. Common features in all depressive disorders include feelings of sadness, emptiness, or irritable mood accompanied by physical symptoms such as fatigue and low energy levels, decreased pain tolerance such as lower back pain and other muscular pains, visual problems or decreased vision, stomach pain and digestive problems, and disruptions in bowel movements, significantly impacting an individual’s functioning. Depending on the severity and intensity of symptoms, as well as the impact of the condition on a person’s functioning, a depressive episode can be classified as mild, moderate, or severe.

Introduction to Microdosing

While the experiences of consuming high doses of psilocybin-containing mushrooms have been extensively studied, recent research has focused on a specific therapeutic approach called microdosing. Microdosing involves the regular use of low doses (5 to 10% of the usual dose) of psychoactive (mind-altering) drugs.

Microdosing Psilocybin

Microdosing Psilocybin  involves the use of low doses (100-300 milligrams of dried mushrooms, equivalent to 0.1 to 0.3 milligrams of pure psilocybin) at regular intervals (every 48 to 72 hours). The effects of psilocybin on the body are dose-dependent, and as the dosage increases, individuals may experience various effects. These effects range from a mild sedating sensation at lower doses to a profound mental jouey at higher doses, including sensory blending such as seeing sounds, hearing colors, feeling unity with nature, and even the sensation of the soul leaving the body. After the substance is cleared from the body, these states retu to normal. The amount of psilocybin used in the microdosing method does not cause alterations in the individual’s perceptual aspects and is devoid of hallucinogenic effects.

This article discusses the scientific aspects of microdosing psilocybin, its effects, research findings, and potential applications.

The benefits of full-dose psychedelics

While more than a thousand early studies linked psychedelic use with beneficial effects , there was a 40-year pause on psychedelic research following the prohibition of these substances. Despite continued prohibition, mode research has revealed the promising potential of LSD and psilocybin for treating alcohol and tobacco dependence , depression, and end-of-life anxiety, while related research on 3,4-methylenedioxymethamphetamine (MDMA) has shown great promise for treating post-traumatic stress disorder. Psychedelics can also increase openness and occasion mystical-type experiences in healthy controls. As full-dose psychedelics appear to aide in the relief of severe, chronic psychiatric conditions (e.g. depression, anxiety, PTSD), milder mental health conces may plausibly be treated by lower, recurring doses. This is especially worth considering if certain full-dose outcomes are found to rely on purely pharmacologic mechanisms rather than primarily on phenomenological experiences.

Limiting microdosing research to topics that have been investigated in full-dose research could prematurely overlook unpredicted and potentially distinct microdosing outcomes. Full-dose research has employed various focal assessments of symptomatology, mood, and personality that are likely applicable to microdosing research, but due to the low doses and lack of perceptual alteration intended in microdosing, other full-dose phenomena, such as ego dissolution and mystical-type experiences, are less relevant to microdosing research. Instead, as a means of preparing for a broad range of outcomes, the present work solicited open-ended reports of benefits and challenges. Additionally, as psychedelic substances act on distinct yet overlapping neural receptor sites, it seems plausible that distinct pattes could emerge for different substances. The present study thus included microdosers who used LSD, psilocybin, or both.